Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole as Adjunctive Treatment for PTSD
NCT01987960Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Dec 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of brexpiprazole orally disintegrating tablet in post-traumatic stress disorder (PTSD), sponsored by Lundbeck. Started Dec 2013; status: terminated.
02
Drugs
brexpiprazole orally disintegrating tablet
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01987960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987960.